Profil Financier
Giammaria Giuliani occupe actuellement le rang #2288 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $1.8 B (-$185 sur 24h).
Giammaria Giuliani is a healthcare investor who owns a minority stake in Royalty Pharma, the world's largest acquirer of pharmaceutical royalties.
Royalty Pharma went public in 2020 and has collected revenue slices of blockbuster drugs like Humira, Imbruvica, Lyrica and Xtandi.
Giammaria and his brother Mario also own stakes in Swiss investment company HBM Healthcare Investments and a number of biotech firms in the U.S.
The brothers share ownership of their family's pharmaceutical company, Giuliani, founded by their great-grandfather Germano in Milan, Italy in 1889.
They also own real estate investments in Europe and the U.S., including a planned commercial and residential project on a maritime platform in Monaco.
The family company's best-known product is Amaro Giuliani, a herbal digestive remedy invented by Germano, a chemist, when he bought a pharmacy in Milan in 1889.